Macleods Pharmaceuticals Ltd — Ofloxacin Exporter Profile
Indian Pharmaceutical Exporter · #3 for Ofloxacin · $12.2M export value · DGFT Verified
Macleods Pharmaceuticals Ltd is the #3 Indian exporter of Ofloxacin with $12.2M in export value and 243 verified shipments. Macleods Pharmaceuticals Ltd holds a 4.1% market share in Ofloxacin exports across 33 countries.
Macleods Pharmaceuticals Ltd — Ofloxacin Export Profile: Buyers & Destinations
Where Does Macleods Pharmaceuticals Ltd Export Ofloxacin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $2.2M | 99 | 24.7% |
| KAZAKISTAN | $812.4K | 20 | 9.3% |
| UZBEKISTAN | $698.8K | 27 | 8.0% |
| NETHERLANDS | $527.0K | 24 | 6.0% |
| SOUTH AFRICA | $523.8K | 28 | 6.0% |
| UNITED STATES | $498.2K | 30 | 5.7% |
| PHILIPPINES | $438.4K | 17 | 5.0% |
| POLAND | $412.4K | 20 | 4.7% |
| PAKISTAN | $354.8K | 19 | 4.1% |
| KAZAKHSTAN | $350.0K | 7 | 4.0% |
Macleods Pharmaceuticals Ltd exports Ofloxacin to 53 countries. The largest destination is FRANCE accounting for 24.7% of Macleods Pharmaceuticals Ltd's Ofloxacin shipments, followed by KAZAKISTAN (9.3%) and UZBEKISTAN (8.0%). These destinations reflect Macleods Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ofloxacin from Macleods Pharmaceuticals Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PLANETPHARMA | FRANCE | $1.9M | 89 |
| FE ADVANCE PHARMACEUTICAL BUSINESS | UZBEKISTAN | $698.8K | 27 |
| BRANCH COMPANY MACLEODS PHARMACEUTI | KAZAKISTAN | $612.4K | 16 |
| MACLEODS PHARMACEUTICALS SA (PTY) | SOUTH AFRICA | $511.3K | 24 |
| BRANCH COMPANY MACLEODS | KAZAKHSTAN | $500.0K | 10 |
| ZUHOOR ELHAM LTD | PAKISTAN | $337.4K | 17 |
| DEPARTMENT OF HEALTH -(PHILIPPINES) | PHILIPPINES | $301.4K | 13 |
| IDA FOUNDATION | NETHERLANDS | $241.6K | 15 |
| DELTA IMPORT - EXPORT MEDICAL CO, | VIETNAM, DEMOCRATIC REP. OF | $200.0K | 4 |
| MACLEODS PHARMA USA.INC | UNITED STATES | $187.9K | 14 |
Macleods Pharmaceuticals Ltd supplies Ofloxacin to 90 buyers globally. The largest buyer is PLANETPHARMA (FRANCE), followed by FE ADVANCE PHARMACEUTICAL BUSINESS (UZBEKISTAN) and BRANCH COMPANY MACLEODS PHARMACEUTI (KAZAKISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ofloxacin Export Value and How Much Does Macleods Pharmaceuticals Ltd Contribute?
India exported $71.8M worth of Ofloxacin through 15,000 shipments from 1094 suppliers to 180 countries, serving 3,093 buyers globally. Macleods Pharmaceuticals Ltd contributes $12.2M to this total, accounting for 4.1% of India's Ofloxacin exports. Macleods Pharmaceuticals Ltd ships Ofloxacin to 53 countries through 90 buyers.
What Is the Average Shipment Value for Macleods Pharmaceuticals Ltd's Ofloxacin Exports?
Macleods Pharmaceuticals Ltd's average Ofloxacin shipment value is $50.0K per consignment, based on 243 shipments totaling $12.2M. The largest destination is FRANCE (24.7% of Macleods Pharmaceuticals Ltd's Ofloxacin exports).
How Does Macleods Pharmaceuticals Ltd Compare to Other Indian Ofloxacin Exporters?
Macleods Pharmaceuticals Ltd ranks #3 among 1094 Indian Ofloxacin exporters with a 4.1% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($12.2M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($10.1M), MICRO LABS LIMITED ($8.4M). Macleods Pharmaceuticals Ltd processed 243 shipments to 33 destination countries.
What Ofloxacin Formulations Does Macleods Pharmaceuticals Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LEVOFLOXACIN 500MG TABLETS, NET CONT: LE | $416.4K | 16 |
| DRUGS AND PHARMACEUTICALS HARMLESSMEDICINES LEVOMAC IV (LEVOFLOXACIN INFUSION 500 MG/100 ML ) | $300.0K | 6 |
| MEDICINES. LEVOFLOXACIN 500MG TABLETS(Ne | $234.4K | 7 |
| LEVOMAC IV (LEVOFLOXACIN INFUSION 500MG/100ML) 1X100ML | $216.7K | 5 |
| OFLOXACIN 200 MG TABLETS 1X10S (45090 P | $200.0K | 4 |
| OFLOXACIN 200 MG TABLETS 1X10S (50000 P | $200.0K | 4 |
| OFLOMAC OD 400 MG CPR B/5 (OFLOXACIN TAB | $200.0K | 4 |
| OFLOMAC OD 400 MG CPR B/5 (OFLOXACIN TA | $165.3K | 4 |
| DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES LEVOFLOXACIN 250 MG TABLETS | $150.0K | 3 |
| DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES LEVOMAC 500(LEVOFLOXACIN 500MG TABLETS) | $150.0K | 3 |
Macleods Pharmaceuticals Ltd exports 271 distinct Ofloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LEVOFLOXACIN 500MG TABLETS, NET CONT: LE with 16 shipments worth $416.4K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Macleods Pharmaceuticals Ltd Compare to Nearest Ofloxacin Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | MACLEODS PHARMACEUTICALS LTD ★ | $12.2M | 243 | 33 | $50.0K |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $10.1M | 202 | 20 | $50.0K |
| 5 | MICRO LABS LIMITED | $8.4M | 373 | 33 | $22.5K |
Macleods Pharmaceuticals Ltd ranks #3 among 1094 Indian Ofloxacin exporters. Average shipment value of $50.0K compared to the market average of $65.6K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and MICRO LABS LIMITED.
Which Indian Ports Ship Ofloxacin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,841 | 12.3% |
| DELHI AIR CARGO ACC (INDEL4) | 1,504 | 10.0% |
| SAHAR AIR | 1,292 | 8.6% |
| NHAVA SHEVA SEA (INNSA1) | 1,262 | 8.4% |
| DELHI AIR | 894 | 6.0% |
| Bombay Air | 655 | 4.4% |
| JNPT/ NHAVA SHEVA SEA | 645 | 4.3% |
| Delhi Air | 361 | 2.4% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ofloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ofloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Macleods Pharmaceuticals Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 458 individual customs records matching Macleods Pharmaceuticals Ltd exporting Ofloxacin, covering 271 formulations to 53 countries via 90 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 180+ countries, 3,093+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ofloxacin Export Data from Macleods Pharmaceuticals Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Macleods Pharmaceuticals Ltd's Ofloxacin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Macleods Pharmaceuticals Ltd
Company Profile
0 products · $0 total trade · 0 categories
Ofloxacin Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Macleods Pharmaceuticals Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ofloxacin. For current shipment-level data, contact TransData Nexus.